Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Free Cash Flow (2020 - 2026)

SkinHealth Systems has reported Free Cash Flow over the past 6 years, most recently at $15.1 million for Q4 2025.

  • Quarterly Free Cash Flow fell 8.18% to $15.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $37.2 million through Dec 2025, up 141.79% year-over-year, with the annual reading at $37.2 million for FY2025, 141.79% up from the prior year.
  • Free Cash Flow was $15.1 million for Q4 2025 at SkinHealth Systems, up from $9.6 million in the prior quarter.
  • Over five years, Free Cash Flow peaked at $20.7 million in Q2 2023 and troughed at -$41.6 million in Q1 2022.
  • The 5-year median for Free Cash Flow is $1.7 million (2021), against an average of -$4.3 million.
  • Year-over-year, Free Cash Flow soared 453.91% in 2021 and then crashed 10557.29% in 2022.
  • A 5-year view of Free Cash Flow shows it stood at -$7.4 million in 2021, then rose by 14.17% to -$6.4 million in 2022, then increased by 18.27% to -$5.2 million in 2023, then surged by 415.47% to $16.4 million in 2024, then decreased by 8.18% to $15.1 million in 2025.
  • Per Business Quant, the three most recent readings for SKIN's Free Cash Flow are $15.1 million (Q4 2025), $9.6 million (Q3 2025), and $9.6 million (Q2 2025).